Clinical trial
Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
NCT00615563 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- January 31, 2008
- Enrollment
- 246 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.